Vancouver, British Columbia (FSCwire) - LED Medical Diagnostics Inc. (“LED” or the
“Company”) (TSX-V: LMD) announces that it is proposing a financing through the issuance of: (i) 12% senior secured debentures of
the Company (the “LED Medical Debentures”) in the aggregate amount of Cdn$150,000, maturing 24 months from the closing date of
the financing (the “Closing Date”); and (ii) 12% senior secured debentures of LED Dental Inc. (the “LED Dental Debentures”), a
wholly-owned direct subsidiary of the Company, in the aggregate amount of Cdn$650,000, maturing 24 months from the Closing Date
(collectively, the LED Medical Debentures and the LED Dental Debentures, the “Debentures”). The Debentures will be issued
to the Bloom Burton Healthcare Lending Trust II, as part of a non-brokered private placement. The LED Medical Debentures
will be issued as units (“Units”) consisting of: (i) LED Medical Debentures in the aggregate principal amount of Cdn$150,000; and
(ii) a total of 320,000 common shares of the Company. The subscription price for the Units will be Cdn$150,000. The
Company intends to grant a total of 1,380,000 common shares of the Company to Bloom Burton Healthcare Lending Trust II as a loan
bonus in connection with the issuance of the LED Dental Debentures.
The Company intends to grant the common shares issued in connection with each Debenture as a loan bonus in
accordance with Exchange Policy 5.1 of the TSX Venture Exchange (the “TSX-V”). The issuance of the Debentures and the
common shares is subject to TSX-V acceptance.
The proceeds will be used by LED for working capital and general corporate purposes.
All securities, other than the LED Dental Debentures, issued in connection with the transaction will be subject to
a hold period expiring four months and one day after the Closing Date. The LED Dental Debentures will be subject to a hold
period expiring four months and one day after the later of: (i) the Closing Date; and (ii) the date that LED Dental Inc. becomes
a “reporting issuer” under Canadian Securities laws in any province or territory of Canada.
About LED Medical Diagnostics Inc.
Founded in 2003 and headquartered in Vancouver, British Columbia, Canada, LED Medical Diagnostics Inc., through its
wholly-owned subsidiaries LED Dental Inc. and LED Dental Ltd., provide dentists and oral health specialists with advanced
diagnostic imaging products and software, in addition to the award-winning VELscope® Vx tissue fluorescence visualization
technology. Backed by an experienced leadership team and dedicated to a higher level of service and support, LED Dental is
committed to providing dental practitioners with the best technology available by identifying and adding leading products to its
growing portfolio.
The Company is currently listed on the TSX-V under the symbol “LMD”, the OTCQX under the symbol “LEDIF”, as well as
the Frankfurt Stock Exchange under the symbol “LME”. For more information, call 884.952.7327 or visit www.leddental.com/investor-relations.
Investor Relations:
Glen Akselrod
Phone: 905.326.1888 ext 10
Email: glen@bristolir.com
Media Contact:
LED Dental
Chris Koch
Phone: 678.293.9413
Email: chris.koch@leddental.com
Corporate Contact:
LED Medical
David Gane, CEO
Phone: 604.434.4614 ext 227
Email: david.gane@leddental.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of
the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
To view this press release as a PDF file, click onto the following link:
public://news_release_pdf/ledmedical12212016_0.pdf
Source: LED Medical Diagnostics Inc. (TSX Venture:LMD, OTCQX:LEDIF, FWB:LME)
To follow LED Medical Diagnostics Inc. on your favorite social media platform or financial websites, please click on the icons
below.
Maximum News Dissemination by FSCwire. http://www.fscwire.com
Copyright © 2016 Filing Services Canada Inc.